Prescription medication · Cannabinoid Antiemetic
dronabinol
Also sold as Marinol. Dronabinol is used to treat loss of appetite and weight loss in adults with Acquired Immune Deficiency Syndrome (AIDS).
Data updated 2026-05-15
- 7,819
- FDA reportsLightly reported
- 9
- InteractionsFew interactions
- $4.20
- Generic price (NADAC)
What the data shows
dronabinol (Marinol) is a prescription Cannabinoid Antiemetic, reported less often than most tracked drugs (7,819 FDA reports), with 9 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
dronabinol (Marinol) is a prescription Cannabinoid Antiemetic. Dronabinol is used to treat loss of appetite and weight loss in adults with Acquired Immune Deficiency Syndrome (AIDS).
Dronabinol capsules contain a synthetic form of THC, the active ingredient in marijuana. It is used to treat loss of appetite in AIDS patients and nausea/vomiting from chemotherapy.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$4.20/unit
Generic Available
Yes (2 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Dronabinol is used to treat loss of appetite and weight loss in adults with Acquired Immune Deficiency Syndrome (AIDS).
Common side effects
Abdominal pain, Dizziness, Feeling very happy
Key warnings
Dronabinol can cause mental and mood changes.
The sections below are summarized in plain English from dronabinol's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Dronabinol works by activating cannabinoid receptors in your brain. These receptors affect appetite, mood, and the sensation of nausea. By activating these receptors, dronabinol can increase appetite and reduce nausea and vomiting.
How to Take It
For appetite loss, the usual starting dose is 2.5 mg twice a day, one hour before lunch and dinner. For nausea and vomiting from chemotherapy, the starting dose is 5 mg/m² taken 1 to 3 hours before chemotherapy. After chemotherapy, take it every 2 to 4 hours for a total of 4 to 6 doses per day. Take the first dose on an empty stomach, at least 30 minutes before eating.
This is a plain-language summary of dronabinol's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.
Pregnancy & Breastfeeding
Dronabinol may harm your unborn baby. Avoid using this medicine if you are pregnant. If you are breastfeeding and have HIV, do not breastfeed due to the risk of passing HIV to your baby.
This is a plain-language summary of dronabinol's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
This is a plain-language summary of dronabinol's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.
Storage
Store dronabinol capsules in the refrigerator between 36° to 46°F (2° to 8°C). Do not freeze.
Side Effects (from patient reports)
Based on 7,819 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for dronabinol, by number of reports
- Feeling sick to your stomach
Feeling sick to your stomach
878 reports
- Feeling very tired
Feeling very tired
696 reports
- Loose, watery stools
Loose, watery stools
604 reports
- Death
Death
593 reports
- Throwing up
Throwing up
581 reports
- Reduced desire to eat
Reduced desire to eat
446 reports
- Discomfort or aching
Discomfort or aching
426 reports
- Loss of body weight
Loss of body weight
413 reports
- Difficulty breathing
Difficulty breathing
377 reports
- Weakness
Weakness
375 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for dronabinol each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where dronabinol sits
dronabinol has more FDA adverse-event reports than 34% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is dronabinol; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 7,819 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
7,819
Reports Mentioning Death
1,639
21.0% of reports — not proof of cause
Hospitalization Reports
3,063
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | NAUSEA | 878 |
| 2 | FATIGUE | 696 |
| 3 | DIARRHOEA | 604 |
| 4 | DEATH | 593 |
| 5 | VOMITING | 580 |
| 7 | DECREASED APPETITE | 446 |
| 8 | PAIN | 427 |
| 9 | WEIGHT DECREASED | 413 |
| 10 | DYSPNOEA | 377 |
| 11 | ASTHENIA | 375 |
| 13 | TOXICITY TO VARIOUS AGENTS | 314 |
| 14 | HEADACHE | 310 |
| 15 | PNEUMONIA | 302 |
| 16 | DRUG ABUSE | 282 |
| 17 | DEHYDRATION | 281 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Dronabinol can cause mental and mood changes. Tell your doctor if you have a history of mental illness. Do not drive or operate heavy machinery until you know how this medicine affects you. This medicine can also affect your heart, causing changes in blood pressure or heart rate. Dronabinol may also increase the risk of seizures.
Known Drug Interactions
(7.3) Highly protein-bound drugs: Potential for displacement of other drugs from plasma proteins; monitor for adverse reactions to concomitant highly protein-bound drugs and narrow therapeutic index drugs (e.g., warfarin, cyclosporine, amphotericin B) when initiating or increasing the dosage of dronabinol capsules. Although this displacement has not been confirmed in vivo , monitor patients for increased adverse reactions to narrow therapeutic index drugs that are highly protein-bound (e.g., warfarin, cyclosporine, amphotericin B) when initiating treatment or increasing the dosage of...
Mechanism: Dronabinol can push warfarin off the proteins in your blood that normally hold it. This leaves more active warfarin in your system, which can increase the risk of bleeding.
What to do: Your doctor should monitor you closely for side effects like unusual bruising or bleeding when starting or changing your dose.
Monitor for potentially increased dronabinol-related adverse reactions when dronabinol capsules are co-administered with inhibitors of CYP2C9 (e.g., amiodarone, fluconazole) and inhibitors of CYP3A4 enzymes (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, erythromycin, grapefruit juice).
Mechanism: Ketoconazole blocks the natural process your body uses to get rid of dronabinol. This can cause dronabinol levels to build up, making side effects more likely.
What to do: Watch for increased side effects like dizziness or confusion, and let your doctor know if you feel unusual while taking both drugs.
Monitor for potentially increased dronabinol-related adverse reactions when dronabinol capsules are co-administered with inhibitors of CYP2C9 (e.g., amiodarone, fluconazole) and inhibitors of CYP3A4 enzymes (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, erythromycin, grapefruit juice).
Mechanism: Fluconazole stops the liver from breaking down dronabinol, which can lead to higher levels of the drug in your blood.
What to do: Your doctor should monitor you closely for increased side effects when taking these drugs together.
(7.3) Highly protein-bound drugs: Potential for displacement of other drugs from plasma proteins; monitor for adverse reactions to concomitant highly protein-bound drugs and narrow therapeutic index drugs (e.g., warfarin, cyclosporine, amphotericin B) when initiating or increasing the dosage of dronabinol capsules. Although this displacement has not been confirmed in vivo , monitor patients for increased adverse reactions to narrow therapeutic index drugs that are highly protein-bound (e.g., warfarin, cyclosporine, amphotericin B) when initiating treatment or increasing the dosage of...
Mechanism: Dronabinol may knock cyclosporine off the proteins it usually sticks to in your blood, making the cyclosporine more active.
What to do: Your doctor should watch you for signs of too much cyclosporine when you start or change your dronabinol dose.
Monitor for potentially increased dronabinol-related adverse reactions when dronabinol capsules are co-administered with inhibitors of CYP2C9 (e.g., amiodarone, fluconazole) and inhibitors of CYP3A4 enzymes (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, erythromycin, grapefruit juice).
Mechanism: Erythromycin slows down the liver enzymes that process dronabinol, which can cause the drug to stay in your body longer.
What to do: Monitor yourself for increased side effects and tell your doctor if you notice any changes.
This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.
Common Questions
Can I drive while taking dronabinol?
What should I do if I feel too high?
Can I take dronabinol with other medications?
How long does it take for dronabinol to start working?
What if dronabinol makes my nausea worse?
Can elderly patients take dronabinol?
What are the signs of a hypersensitivity reaction?
Is dronabinol the same as marijuana?
Can dronabinol cause mental health problems?
What should I do if I have side effects?
What are the common side effects of dronabinol?
Does dronabinol interact with other medications?
What drug class is dronabinol?
Is dronabinol safe during pregnancy?
Related Medications in Cannabinoid Antiemetic
Other drugs grouped near dronabinol - same-class peers and common alternatives.
alosetron
Lotronex
Alosetron (Lotronex) is a medicine for women with severe diarrhea-predominant irritable bowel syndrome (IBS).
Compare with dronabinol →
aprepitant
Emend
Aprepitant (Emend) is a medicine that helps prevent nausea and vomiting.
Compare with dronabinol →
bisacodyl
Dulcolax
Bisacodyl is a medicine that helps you have a bowel movement.
Compare with dronabinol →
bismuth subsalicylate
Pepto-Bismol
Bismuth subsalicylate (Pepto-Bismol) is a medicine that can treat diarrhea and upset stomach.
Compare with dronabinol →
cimetidine
Tagamet
Cimetidine (Tagamet) reduces stomach acid.
Compare with dronabinol →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on dronabinol
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for dronabinol
The FDA label for dronabinol (sold under brand names such as Marinol) classifies it as a prescription-only medication in the Cannabinoid Antiemetic class. Dronabinol is used to treat loss of appetite and weight loss in adults with Acquired Immune Deficiency Syndrome (AIDS). Official labeling lists 8 commonly reported side effects, including Abdominal pain, Dizziness, Feeling very happy.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 7,819 voluntary reports. The database also lists 9 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $4.20.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: January 7, 2025
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages